Literature DB >> 36029453

Multi-omics analysis identifies potential mechanisms by which high glucose accelerates macrophage foaming.

Jie Qi1,2, Ying Lv3, Ni-Er Zhong2, Wen-Qi Han2, Qi-Ling Gou2, Chao-Feng Sun4.   

Abstract

Atherosclerotic morbidity is significantly higher in the diabetic population. Hyperglycemia, a typical feature of diabetes, has been proven to accelerate foam cell formation. However, the molecular mechanisms behind this process remain unclear. In this study, LPS and IFN-γ were used to convert THP-1-derived macrophages into M1 macrophages, which were then activated with ox-LDL in either high glucose or normal condition. We identified lipids within macrophages by Oil red O staining and total cholesterol detection. The genes involved in lipid absorption, efflux, inflammation, and metabolism were analyzed using qRT-PCR. The mechanisms of high glucose-induced foam cell formation were further investigated through metabolomics and transcriptomics analysis. We discovered that high glucose speed up lipid accumulation in macrophages (both lipid droplets and total cholesterol increased), diminished lipid efflux (ABCG1 down-regulation), and aggravated inflammation (IL1B and TNF up-regulation). Following multi-omics analysis, it was determined that glucose altered the metabolic and transcriptional profiles of macrophages, identifying 392 differently expressed metabolites and 293 differentially expressed genes, respectively. Joint pathway analysis suggested that glucose predominantly disrupted the glycerolipid, glycerophospholipid, and arachidonic acid metabolic pathways in macrophages. High glucose in the glyceride metabolic pathway, for instance, suppressed the transcription of triglyceride hydrolase (LIPG and LPL), causing cells to deposit excess triglycerides into lipid droplets and encouraging foam cell formation. More importantly, high glucose triggered the accumulation of pro-atherosclerotic lipids (7-ketocholesterol, lysophosphatidylcholine, and glycerophosphatidylcholine). In conclusion, this work elucidated mechanisms of glucose-induced foam cell formation via a multi-omics approach.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Foam cell formation; High glucose; Lipid metabolism disorders; Sequence analysis

Year:  2022        PMID: 36029453     DOI: 10.1007/s11010-022-04542-w

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.842


  5 in total

Review 1.  Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities.

Authors:  Magnus Bäck; Arif Yurdagul; Ira Tabas; Katariina Öörni; Petri T Kovanen
Journal:  Nat Rev Cardiol       Date:  2019-07       Impact factor: 32.419

2.  Impact of trimethylamine N-oxide (TMAO) metaorganismal pathway on cardiovascular disease.

Authors:  Yongzhong Zhao; Zeneng Wang
Journal:  J Lab Precis Med       Date:  2020-04-20

3.  Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-κB.

Authors:  Marcus M Seldin; Yonghong Meng; Hongxiu Qi; WeiFei Zhu; Zeneng Wang; Stanley L Hazen; Aldons J Lusis; Diana M Shih
Journal:  J Am Heart Assoc       Date:  2016-02-22       Impact factor: 5.501

4.  Alveolar Type II Cells or Mesenchymal Stem Cells: Comparison of Two Different Cell Therapies for the Treatment of Acute Lung Injury in Rats.

Authors:  Raquel Guillamat-Prats; Marta Camprubí-Rimblas; Ferranda Puig; Raquel Herrero; Neus Tantinyà; Anna Serrano-Mollar; Antonio Artigas
Journal:  Cells       Date:  2020-07-31       Impact factor: 6.600

5.  Signaling Pathways Potentially Responsible for Foam Cell Formation: Cholesterol Accumulation or Inflammatory Response-What is First?

Authors:  Alexander N Orekhov; Vasily N Sukhorukov; Nikita G Nikiforov; Marina V Kubekina; Igor A Sobenin; Kathy K Foxx; Sergey Pintus; Philip Stegmaier; Daria Stelmashenko; Alexander Kel; Anastasia V Poznyak; Wei-Kai Wu; Artem S Kasianov; Vsevolod Y Makeev; Ichiro Manabe; Yumiko Oishi
Journal:  Int J Mol Sci       Date:  2020-04-14       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.